Patents by Inventor Ernst Küchler

Ernst Küchler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7282599
    Abstract: The invention discloses a use of dithiocarbamate compounds having the structural formula R1R2NCS2H, in which R1 and R2, independently of each other, represent a straight or branched C1-C4 alkyl, or, with the nitrogen atom, form an aliphatic ring with 4 to 6 C atoms, in which R1, R2, or the aliphatic ring is optionally substituted with one or more substituents selected from OH, NO2, NH2, COOH, SH, F, Cl, Br, I, methyl or ethyl, and oxidized forms of these compounds, in particular dimers thereof, as well as pharmaceutically acceptable salts thereof, to prepare an agent for treating or preventing an infection by RNA viruses which attack the respiratory tract and cause disease there.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: October 16, 2007
    Assignee: Avir Green Hills Biotechnology Research Devlopment Trade AG
    Inventors: Elisabeth Gaudernak, Andreas Grassauer, Ernst Küchler, Thomas Muster, Joachim Seipelt
  • Patent number: 5712245
    Abstract: A substantially pure receptor with binding activity for rhinoviruses of the minor human receptor group is disclosed, which has the following characteristics:(a) a molecular weight of 120 kD on a polyacrylamide gel in the presence of SDS;(b) a sedimentation constant, determined by sucrose gradient centrifugation in the presence of detergents, corresponding to about 28.4 S;(c) is bound by Lens culinaris lectin;(d) is not bound by heparin-sepharose;(e) is bound irreversibly to an anion exchanger;(f) has binding activity which is insensitive to neuraminidase;(g) consists of sub-units connected by intermolecular disulfide bridges;(h) shows no binding activity to rhinoviruses in the presence of EDTA; and(i) has a binding activity to rhinoviruses which is only slightly influenced by iodoacetamide.Methods of providing protection against infection by rhinoviruses of the minor receptor group with the substantially pure receptor of the present invention, are also disclosed.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: January 27, 1998
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dieter Blaas, Ernst Kuechler, Harald Mischak, Christoph Neubauer
  • Patent number: 5603932
    Abstract: A substantially pure receptor with binding activity for rhinoviruses of the minor human receptor group is disclosed, which has the following characteristics:(a) a molecular weight of 120 kD on a polyacrylamide gel in the presence of SDS;(b) a sedimentation constant, determined by sucrose gradient centrifugation in the presence of detergents, corresponding to about 28.4 S;(c) is bound by Lens culinaris lectin;(d) is not bound by heparin-sepharose;(e) is bound irreversibly to an anion exchanger;(f) has binding activity which is insensitive to neuraminidase;(g) consists of sub-units connected by intermolecular disulfide bridges;(h) shows no binding activity to rhinoviruses in the presence of EDTA; and(i) has a binding activity to rhinoviruses which is only slightly influenced by iodoacetamide.A receptor subunit of the above-described receptor, produced by complete reduction of said receptor, is also disclosed.
    Type: Grant
    Filed: April 23, 1996
    Date of Patent: February 18, 1997
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dieter Blaas, Ernst Kuechler, Harald Mischak, Christoph Neubauer
  • Patent number: 5447840
    Abstract: A substantially pure receptor with binding activity for rhinoviruses of the small receptor group is disclosed, which has the following characteristics:(a) a molecular weight of 120 kD on a polyacrylamide gel in the presence of SDS;(b) a sedimentation constant, determined by sucrose gradient centrifugation in the presence of detergents, corresponding to about 28.4 S;(c) is bound by Lens culinaris lectin;(d) is not bound by heparin-sepharose;(e) is bound irreversibly to an anion exchanger;(f) has binding activity which is insensitive to neuraminidase;(g) consists of sub-units connected by intermolecular disulfide bridges;(h) shows no binding activity to rhinoviruses in the presence of EDTA; and(i) has a binding activity to rhinoviruses which is only slightly influenced by iodoacetamide.A receptor subunit of the above-described receptor, produced by complete reduction of said receptor, is also disclosed.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: September 5, 1995
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dieter Blaas, Ernst Kuechler, Harald Mischak, Christoph Neubauer
  • Patent number: 5304636
    Abstract: A substantially pure receptor with binding activity for rhinoviruses of the small receptor group is disclosed, which has the following characteristics:(a) a molecular weight of 120 KD on a polyacrylamide gel in the presence of SDS;(b) a sedimentation constant, determined by sucrose gradient centrifugation in the presence of detergents, corresponding to about 28.4 S;(c) is bound by Lens culinaris lectin;(d) is not bound by heparin-sepharose;(e) is bound irreversibly to an anion exchanger;(f) has binding activity which is insensitive to neuraminidase;(g) consists of sub-units connected by intermolecular disulfide bridges;(h) shows no binding activity to rhinoviruses in the presence of EDTA; and(i) has a binding activity to rhinoviruses which is only slightly influenced by iodoacetamide.A receptor subunit of the above-described receptor, produced by complete reduction of said receptor, is also disclosed.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: April 19, 1994
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Dieter Blaas, Ernst Kuechler, Harald Mischak, Christoph Neubauer
  • Patent number: 5149783
    Abstract: This invention relates to a DNA molecule or a functional derivative thereof coding for a fusion protein, the fusion protein comprising an enzymatically active component and a non-enzymatically active polypeptide component which may be cleaved therefrom, an expression system which contains the DNA molecule, the use thereof as a test system for inhibitors of viral proteases, and an assay for identifying viral inhibitors.
    Type: Grant
    Filed: December 23, 1988
    Date of Patent: September 22, 1992
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Wolfgang Sommergruber, Friederike Fessl, Ernst Kuechler, Dieter Blaas, Timothy Skern, Manfred Zorn, Markus Duechler, Heinrich Kowalski, Peter Volkmann, Ingrid Maurer-Fogy, Peter Pallai